MP

Mohan Padmanabharao Harish

Active Director Director DIN 09324539
DIN 09324539 First appointment Sep 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohan Padmanabharao Harish

Data last updated:

Mohan Padmanabharao Harish is a Director at Srivari Medtech Private Limited (since 2021). The company operates in Healthcare.

DIN 09324539
Primary Designation Director
Industry Healthcare
First Appointment 18 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srivari Medtech Private Limited U85100TN2021PTC146301
Director18 Sep 20212021Active

Board colleagues of Mohan Padmanabharao Harish

NameDINCompanyDesignation
Ganesan Deepika09324540Srivari Medtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Srivari Medtech Private Limited
Premium access

Shareholding and investment profile for Mohan Padmanabharao Harish

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohan Padmanabharao Harish

Mohan Padmanabharao Harish currently holds 1 directorship: Srivari Medtech Private Limited (Director, since 18 Sep 2021).

Mohan Padmanabharao Harish was first appointed on 18 Sep 2021 as Director at Srivari Medtech Private Limited.

The current boards of Mohan Padmanabharao Harish's companies include Ganesan Deepika (Srivari Medtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available